Trump nominates Chris Klomp as deputy secretary of Health and Human Services.
President Donald Trump announced the nomination of Chris Klomp, a 45-year-old tech entrepreneur and current chief counselor at HHS, to serve as deputy secretary under Health Secretary Robert F. Kennedy Jr. Klomp has been overseeing HHS operations since his February promotion and has led negotiations with pharmaceutical companies on drug pricing agreements. The nomination requires Senate confirmation.
13
Divergence score
3 outlets covered it, splitting into 3 framing camps across 1 bias group.
3 camps
1 bias group
The spectrum · how 3 outlets placed this story
LeftCenterRight
Politico
Axios
Bloomberg
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Politico asks how much savings Americans are getting from Klomp's secret drug deals. Axios and Bloomberg highlight his praise from health industry leaders and business credentials.
How each outlet covered it
No left-right split here
Coverage clusters in the center and international press. Here is each take as it stands.
Center & international coverage
“Trump nominates new top deputy to RFK Jr.”
“Trump nominates Chris Klomp for deputy health secretary”
“Trump Taps Chris Klomp as No. 2 Official at RFK Jr.'s HHS”
8 tracked claims across 3 outlets
Fact ledger
All8Claimed3Corroborated5
1/3
Claimed
The drug pricing deals are secret and it is unclear how much savings Americans are receiving.
Corroborated
Disputed
7 more tracked claimsSign up free to see the full ledger